Listed

Maximus, Inc.: Form 10-Q for the period ended Mar 31, 2024

Filed with the SEC on May 9, 2024 and accepted by EDGAR at May 9, 2024, 18:40 ET.

Share

Management's discussion and analysis

As filed, 36,945 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

The following discussion is intended to help the reader understand our business, financial condition, results of operations, liquidity and capital resources. You should read this discussion in conjunction with "Risk Factors," "Special Note Regarding Forward-Looking Statements," and our financial statements and related notes included in our Annual Report on Form 10-K for fiscal year 2023 filed with the Securities and Exchange Commission on November 16, 2023 (the "2023 Form 10-K") and elsewhere in this Quarterly Report on Form 10-Q, as applicable.

Business Overview

Maximus, under its mission of Moving People Forward, helps millions of people access the vital government services they need. With over 45 years of experience working with local, state, federal, and international government clients, we proudly design, develop, and deliver innovative and impactful programs that change lives. We are driven to strengthen communities and improve the lives of those we serve.

We create value for our customers through our ability to translate health and human services public policy into operating models that achieve outcomes for governments at scale. Our work covers a broad array of services, including the operation of large health insurance eligibility and enrollment programs; clinical services, including assessments, appeals, and independent medical reviews; and technology services. These services benefit from a market with increasing demographic demand, constrained government budgets, and an increased focus on technology. We have also shown the ability to move quickly, most notably with the swift establishment of public health and safety initiatives during the recent COVID-19 pandemic, such as vaccine information hotlines and unemployment insurance services. Our organic growth through increased contract scope and entry into new markets has been supplemented by strategic acquisitions. Most notably, our acquisitions of VES Group, Inc. ("VES"), a leading provider of medical disability examinations ("MDE") to the United States ("U.S.") Department of Veterans Affairs ("VA"); the Federal business of Attain, LLC ("Attain"), a provider of technology consulting and systems integration services; and a service contract with the U.S. Department of Education, rebranded as "Aidvantage," have supplemented our organic growth and allowed expansion into new markets.

In fiscal year 2022, we introduced our refreshed three-to-five-year strategic plan, which we believe will further expand our business. Having moved past the major impacts of the COVID-19 pandemic, we believe we are in a strong position to capitalize on organic growth opportunities in our core business, as reflected in the following three pillars of our refreshed strategy.

  • Customer Services, Digitally Enabled. Elevate the customer experience to achieve higher levels of satisfaction, performance, and outcomes through intelligent automation and cognitive computing.
  • Future of Health. Help governments meet the rising demand for health services by growing our clinical capabilities to improve the health of people and their communities.
  • Advanced Technologies for Modernization. Further our credibility as a technology leader, enabling the transformation of government programs to be resilient, dynamic, integrated, and equitable.

Financial Overview

A number of factors have affected our results for the three and six months ended March 31, 2024. More detail on these changes is presented below within our "Results of Operations" section.

Results of Operations

The following table sets forth items from our consolidated statements of operations for the three and six months ended March 31, 2024, and March 31, 2023.

(dollars in thousands, except per share data)

Table MD&A 1: Consolidated Results of Operations For the Three Months Ended March 31, 2024 March 31, 2023 For the Six Months Ended March 31, 2024 March 31, 2023
Revenue $1,348,357 $1,206,852 $2,675,398 $2,456,098
Cost of revenue 1,030,768 978,249 2,057,755 1,982,748
Gross profit 317,589 228,603 617,643 473,350
Gross profit percentage 23.6% 18.9% 23.1% 19.3%
Selling, general, and administrative expenses 168,454 142,448 337,649 288,900
Selling, general, and administrative expenses as a percentage of revenue 12.5% 11.8% 12.6% 11.8%
Amortization of intangible assets 21,641 23,650 44,990 47,168
Operating income 127,494 62,505 235,004 137,282
Operating margin 9.5% 5.2% 8.8% 5.6%
Interest expense 20,366 20,999 41,873 42,605
Other expense/(income), net (822) (818) (334) (1,084)
Income before income taxes 107,950 42,324 193,465 95,761
Provision for income taxes 27,440 10,536 48,807 23,978
Effective tax rate 25.4% 24.9% 25.2% 25.0%
Net income $80,510 $31,788 $144,658 $71,783
Earnings per share:
Basic $1.31 $0.52 $2.36 $1.17
Diluted $1.31 $0.52 $2.35 $1.17

Our business segments have different factors driving revenue fluctuations and profitability. The sections that follow cover these segments in greater detail. Our revenue reflects fees earned for services provided. Cost of revenue consists of direct costs related to labor and related overhead, subcontractor labor, outside vendors, rent, and other direct costs. The largest component of cost of revenue, approximately two-thirds, is labor, including subcontracted labor.

Table MD&A 2: Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended March 31, 2024

(dollars in thousands)

Revenue Dollars % Change Cost of Revenue Dollars % Change Gross Profit Dollars % Change
Three Months Ended March 31, 2023 $1,206,852 $978,249 $228,603
Organic effect 152,614 12.6% 65,360 6.7% 87,254 38.2%
Disposal of businesses (14,267) (1.2)% (15,442) (1.6)% 1,175 0.5%
Currency effect compared to the prior period 3,158 0.3% 2,601 0.3% 557 0.2%
Three Months Ended March 31, 2024 $1,348,357 11.7% $1,030,768 5.4% $317,589 38.9%

23

Table MD&A 3: Changes in Revenue, Cost of Revenue, and Gross Profit for the Six Months Ended March 31, 2024

(dollars in thousands)

Revenue Dollars % Change Cost of Revenue Dollars % Change Gross Profit Dollars % Change
Six Months Ended March 31, 2023 $2,456,098 $1,982,748 $473,350
Organic effect 239,413 9.7% 98,195 5.0% 141,218 29.8%
Disposal of businesses (28,003) (1.1)% (30,050) (1.5)% 2,047 0.4%
Currency effect compared to the prior period 7,890 0.3% 6,862 0.3% 1,028 0.2%
Six Months Ended March 31, 2024 $2,675,398 8.9% $2,057,755 3.8% $617,643 30.5%

Selling, general, and administrative ("SG&A") expenses

SG&A expense consists of indirect costs related to general management, marketing, and administration. It is primarily composed of labor costs. These costs may be incurred at a segment level, for dedicated resources that are not client-facing, or at a corporate level. Corporate costs are allocated to segments on a consistent and rational basis. Fluctuations in our SG&A expense are primarily driven by changes in our administrative cost base, which is not directly driven by changes in our revenue. As part of our work for the U.S. federal government and many states, we allocate these costs using a methodology driven by the U.S. Federal Cost Accounting Standards.

Our SG&A expense increased by $48.7 million for the six months ended March 31, 2024 compared to the same period in fiscal year 2023, primarily driven by growth in our business, including additional spending in anticipation of future work.

Amortization of intangible assets

Our intangible asset amortization for the three and six months ended March 31, 2024 has declined compared to the same period in fiscal year 2023. This decline reflects the amortization in full of intangible assets from our Aidvantage acquisition.

Our balance sheet includes intangible assets of $502 million and $40 million from the 2021 VES and 2019 GDIT acquisitions, respectively. These assets, comprising customer relationships, technology, and a medical provider network, continue to support contracts acquired with these acquisitions. The greater part of these assets are being amortized over the remaining nine and five years, respectively. In the event that our expectations change with respect to these acquired contracts, the value of these assets and the estimated remaining lives of these assets may need to be adjusted.

Interest Expense

Our interest expense has remained consistent year-over-year as declines in our debt balance are offset by increased interest rates. We have sought to mitigate our risk by fixing interest rates on approximately half of our debt, and our near-term capital allocation plan continues to prioritize reducing our debt using our free cash flow.

Provision for Income Taxes

Our effective income tax rate for the three and six months ended March 31, 2024, was 25.4% and 25.2%, respectively, compared to 24.9% and 25.0% for the three and six months ended March 31, 2023. For fiscal year 2024, we expect the effective tax rate to be between 24.5% and 25.5%.

U.S. Federal Services Segment

Our U.S. Federal Services Segment delivers end-to-end solutions that help various U.S. federal government agencies better deliver on their mission, including program operations and management, clinical services, and technology solutions. This segment also includes appeals and assessments services, system and application development, Information Technology ("IT") modernization, and maintenance services. Certain state-based assessments and appeals work that is part of the segment's heritage continues to be managed within this segment. Under Technology Consulting Services ("TCS"), the segment executes on its digital strategy to deliver technology solutions that advance agency missions, including the challenge to modernize, provide better customer experience, and drive process efficiencies. The segment continues to expand its clinical solutions through VES, which manages the clinical evaluation process for U.S. veterans and service members on behalf of the VA.

Table MD&A 4: U.S. Federal Services Segment - Financial Results

(dollars in thousands)

For the Three Months Ended March 31, 2024 March 31, 2023 For the Six Months Ended March 31, 2024 March 31, 2023
Revenue $701,702 $584,075 $1,378,780 $1,202,242
Cost of revenue 538,365 461,201 1,058,781 956,674
Gross profit 163,337 122,874 319,999 245,568
Selling, general, and administrative expenses 79,867 75,050 167,722 146,699
Operating income 83,470 47,824 152,277 98,869
Gross profit percentage 23.3% 21.0% 23.2% 20.4%
Operating margin percentage 11.9% 8.2% 11.0% 8.2%

Our revenue and cost of revenue for the three months ended March 31, 2024, increased 20.1% and 16.7%, respectively. For the six months ended March 31, 2024, revenue and cost of revenue growth was 14.7% and 10.7%, respectively. All growth in fiscal year 2024 was organic.

Our revenue and margin growth has principally been driven by volume growth and strong performance on our contracts with the VA relating to MDEs.

We anticipate that our U.S. Federal Services Segment will continue to grow for the remainder of fiscal year 2024, driven primarily by additional volumes anticipated in MDEs. We anticipate that our full-year operating margin will be around 12%.

Recently, unique circumstances have led to potential recompetes of two significant contracts held by Maximus:

  • The Centers for Medicare & Medicaid Services (CMS) has taken steps to recompete the Contact Center Operations (CCO) contract awarded to us in 2022 at a value of $6.6 billion over a base plus nine-year period of performance. The earlier-than-expected action is for the express purpose of including a labor harmony agreement requirement. Meanwhile, Maximus has consistently met or exceeded all contractual service levels with uninterrupted operations and driven the highest independently measured customer satisfaction in the history of the program. CMS indicates a formal Request for Proposal (RFP) process is expected to commence on or around May 16, 2024. We anticipate continuing to work on this contract uninterrupted until the recompete process is completed and that, as the incumbent, we have significant operational advantages.
  • A majority of the MDE contracts under the VA, which comprise our acquired VES business, had ceilings on claims volumes at the time of award in 2018. Volumes have significantly increased since the passage of the PACT Act, thereby requiring a rebid process. In fiscal year 2023, these contracts together represented between 10% and 15% of total Company revenue. We anticipate continuing to work on these contracts uninterrupted until the recompete process is completed and that, as the incumbent, we have significant operational advantages.

U.S. Services Segment

Our U.S. Services Segment provides a variety of business process services ("BPS"), such as program administration, assessments, and related consulting work for U.S. state and local government programs. These services support a variety of programs, including the Affordable Care Act ("ACA"), Medicaid, the Children's Health Insurance Program ("CHIP"), Temporary Assistance to Needy Families ("TANF"), and child support programs. Previously, this segment suffered from reduced operating leverage resulting from the pause in Medicaid redeterminations during the COVID-19 pandemic. Redeterminations resumed in late fiscal year 2023, meaning fiscal year 2024 and beyond are demonstrating and should continue to demonstrate recovery of operating leverage and related margin improvement.

Table MD&A 5: U.S. Services Segment - Financial Results

(dollars in thousands)

For the Three Months Ended March 31, 2024 March 31, 2023 For the Six Months Ended March 31, 2024 March 31, 2023
Revenue $486,115 $449,703 $975,960 $889,181
Cost of revenue 355,993 363,687 727,475 719,567
Gross profit 130,122 86,016 248,485 169,614
Selling, general, and administrative expenses 62,201 43,415 114,501 89,257
Operating income 67,921 42,601 133,984 80,357
Gross profit percentage 26.8% 19.1% 25.5% 19.1%
Operating margin percentage 14.0% 9.5% 13.7% 9.0%

Our revenue and cost of revenue for the three months ended March 31, 2024, increased 8.1% and decreased 2.1%, respectively, compared to the three months ended March 31, 2023. For the six months ended March 31, 2024, our revenue and cost of revenue increased 9.8% and 1.1%, respectively, compared to the six months ended March 31, 2023. All growth was organic.

Growth in the first half of fiscal year 2024 was principally from Medicaid redetermination activities, supplemented by a large, state-based assessment program which has ramped up in recent quarters.

Our margins in the first half of fiscal year 2024 have received the benefit of additional volumes from redetermination activity, that we anticipate returning to normal levels through the second half of the year. We anticipate a full-year operating profit margin of between 11% and 14%.

Outside the U.S. Segment

Our Outside the U.S. Segment provides BPS for international governments, transforming the lives of people around the world. Helping people find employment, access vital support, and remain healthy, these services include health and disability assessments, program administration for employment services, wellbeing solutions, and other job seeker-related services. We support programs and deliver services in the United Kingdom, including the Health Assessment Advisory Service and the recently awarded replacement contract to start in 2024, Functional Assessment Services, and Restart; and Australia, including Workforce Australia, and other employment support and job seeker services worldwide.

Table MD&A 6: Outside the U.S. Segment - Financial Results

(dollars in thousands)

For the Three Months Ended March 31, 2024 March 31, 2023 For the Six Months Ended March 31, 2024 March 31, 2023
Revenue $160,540 $173,074 $320,658 $364,675
Cost of revenue 136,410 153,361 271,499 306,507
Gross profit 24,130 19,713 49,159 58,168
Selling, general, and administrative expenses 23,460 23,425 48,601 51,814
Operating income/(loss) 670 (3,712) 558 6,354
Gross profit percentage 15.0% 11.4% 15.3% 16.0%
Operating margin percentage 0.4% (2.1)% 0.2% 1.7%

26

Table MD&A 7: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Three Months Ended March 31, 2024

(dollars in thousands)

Revenue Amount % Change Cost of Revenue Amount % Change Gross Profit Amount % Change
Three Months Ended March 31, 2023 $173,074 $153,361 $19,713
Organic effect (1,425) (0.8)% (4,110) (2.7)% 2,685 13.6%
Disposal of businesses (14,267) (8.2)% (15,442) (10.1)% 1,175 6.0%
Currency effect compared to the prior period 3,158 1.8% 2,601 1.7% 557 2.8%
Three Months Ended March 31, 2024 $160,540 (7.2)% $136,410 (11.1)% $24,130 22.4%

Table MD&A 8: Outside the U.S. Segment - Changes in Revenue, Cost of Revenue, and Gross Profit for the Six Months Ended March 31, 2024

(dollars in thousands)

Revenue Amount % Change Cost of Revenue Amount % Change Gross Profit Amount % Change
Six Months Ended March 31, 2023 $364,675 $306,507 $58,168
Organic effect (23,904) (6.6)% (11,820) (3.9)% (12,084) (20.8)%
Disposal of businesses (28,003) (7.7)% (30,050) (9.8)% 2,047 3.5%
Currency effect compared to the prior period 7,890 2.2% 6,862 2.2% 1,028 1.8%
Six Months Ended March 31, 2024 $320,658 (12.1)% $271,499 (11.4)% $49,159 (15.5)%

This segment recorded a break-even margin in the first quarter of fiscal year 2024 as management undertakes steps to improve performance and deliver consistent profitability in this part of our organization. These steps included the divestiture in fiscal year 2024 of our employment services business in Canada and all of our operations in Italy and Singapore. In fiscal year 2023, we disposed of our commercial practice in the United Kingdom and our Swedish operations.

In the first quarter of fiscal year 2023, this segment received a significant benefit from higher employment services volumes, which did not recur in the second quarter. Revenue from our employment services contracts include payments based upon our ability to place individuals in long-term, sustained employment. We recognize this revenue over the period of performance using estimates of these outcomes, which are typically based upon past performance. Changes in these estimates may have a significant effect on our revenue.

The improvement in the valuation of the British Pound provided an additional benefit to revenue and profit in the first six months of fiscal year 2024.

We anticipate our Outside the United States Segment will yield slightly above break-even operating margin for the full year.

Liquidity and Capital Resources

Our primary sources of liquidity are cash on hand, cash from operations, and availability under our revolving credit facilities. As of March 31, 2024, we had $77.4 million in cash and cash equivalents. We believe that our current cash position, access to our revolving debt, and cash flow generated from operations should be sufficient for our operating requirements for the next 12 months and beyond, including enabling us to fund required long-term debt repayments, dividends and any share purchases we might choose to make. See "Note 6. Debt and Derivatives" to the Consolidated Financial Statements for a more detailed discussion of our debt financing arrangements.

We have included the following table showing our debt balances as of March 31, 2024, and their effective interest rates.

Table MD&A 9: Balances and interest rates as of March 31, 2024

(dollars in thousands)

March 31, 2024 Carrying value Effective cash interest rate Interest rate basis
Term Loan A - Unhedged $218,125 6.93% Term SOFR reset monthly plus margin. (1)
Term Loan A - Hedged though May 2026 500,000 3.91% Fixed rate of 2.31% plus margin. (1)
Term Loan A - Hedged through September 2024 150,000 5.98% Fixed rate of 4.38% plus margin. (1)
Term Loan B 343,170 7.43% Term SOFR (variable reset) plus 2% margin.
Debt held by international subsidiaries 4,892 6.16% Floating rate, reset quarterly.
Debt Principal $1,216,187

(1) Applicable margin ranges between 1% and 2%, based on our leverage ratio.

Our effective cash interest rate reflects the drivers of our cash interest payments as of March 31, 2024, which can change based upon the reset of the rates. Including the amortization of the upfront payments, our effective interest rate as of March 31, 2024, is 5.9%.

The below table summarizes our change in cash, cash equivalents, and restricted cash.

Table MD&A 10: Net Change in Cash and Cash Equivalents and Restricted Cash

(in thousands)

Operating activities: For the Six Months Ended March 31, 2024 March 31, 2023
Net cash provided by operating activities $152,096 $175,037
Net cash used in investing activities (62,475) (24,627)
Net cash used in financing activities (94,487) (171,671)
Effect of foreign exchange rates on cash and cash equivalents and restricted cash 1,115 3,186
Net change in cash and cash equivalents and restricted cash $(3,751) $(18,075)

Net Cash Provided By Operating Activities

Our net income for the first six months of fiscal year 2024 increased by $72.9 million compared to the six months ended March 31, 2023; notwithstanding this, our operating cash flows for the same period declined by $22.9 million. The principal reason for the decline was the timing of certain cash collections, with approximately $100 million received during the first week of April 2024.

Our Days Sales Outstanding ("DSO") at March 31, 2024, were 62 days, compared with 60 days at year end.

Net Cash Used In Investing Activities

We continue to make investments in our capital base, most notably in upgrading technology on our Federal MDE contracts. In addition:

  • In the first half of fiscal year 2024, we have invested $18 million in acquiring part of one of our long-term vendors;
  • In the first half of fiscal year 2023, we received payment from the sale of our Swedish business and a small commercial practice in the United Kingdom;
  • In the first half of fiscal year 2024, we received a further installment payment on the sale of the U.K. business, as well as payment from the sale of our businesses in Italy, Singapore and our Canadian employment business.

Net Cash Used In Financing Activities

Financing activities in the first half of fiscal year 2024 include approximately $40 million of net debt repayment and $50 million related to servicing of stock through dividends or net settlement of RSU and PSU vesting. A further $8 million was incurred in payments for the acquisitions of Aidvantage in the U.S., and BZ Bodies (BZB), in the United Kingdom, which were based upon post-acquisition performance of the businesses.

Our financing cash flows in the first half of fiscal year 2023 included early debt payments. We also made a payment of $60.7 million to the acquirer of some of our accounts receivable balances, relating to funds received on their behalf.

Credit Facilities

Our principal debt agreement is with JPMorgan Chase Bank N.A. (the "Credit Agreement"). At March 31, 2024, we owed $1.21 billion under the Credit Agreement, with access to an additional $600 million through a revolving credit facility. Mandatory repayments are required under this agreement through May 2028, when the agreement ends, and must be renegotiated or the funds repaid.

The Credit Agreement contains a number of covenants with which we are expected to comply. Failure to meet these requirements would result in a need to renegotiate the agreement or a requirement to repay our outstanding debt in full. There are two financial covenants, both defined in the Credit Agreement.

  • Our Consolidated Net Total Leverage Ratio means, for any twelve-month period, the ratio of our Funded Debt (as defined by our Credit Agreement), offset by up to $75 million of unrestricted cash (Consolidated Net Total Leverage), against our Consolidated EBITDA (as defined by the Credit Agreement). To comply with our Credit Agreement, this ratio cannot exceed 4.00:1.00 at the end of each quarter, with a step up to 4.50:1.00 under certain circumstances. This ratio also determines both our interest rate and the charge we pay on the unused component of our revolving credit facility, with the charge increasing as the leverage ratio increases.
  • Our Consolidated Net Interest Coverage Ratio means, for any twelve-month period, the ratio of our Consolidated EBITDA against our Consolidated Net Interest Expense, as defined by the Credit Agreement. To comply with our Credit Agreement, this ratio cannot be less than 3.00:1.00 at the end of each quarter.

Consolidated EBITDA also drives certain permissions within the Credit Agreement, such as the level of investment we are entitled to make without seeking additional approval from our lenders.

Our Credit Agreement defines Consolidated EBITDA, as well as other components of the calculations above. The definition of Consolidated EBITDA requires us to include adjustments not typically included within EBITDA, including unusual, non-recurring expenses, certain non-cash adjustments, the pro forma effects of acquisitions and disposals, and estimated synergies from acquisitions. As a result, Consolidated EBITDA as defined by the Credit Agreement may not be comparable to EBITDA or related or similarly-titled measures presented by other companies.

We have summarized below the components of our two financial ratio calculations, including the components of Consolidated EBITDA as defined by the Credit Agreement which are included within our financial statements. At March 31, 2024, we were in compliance with all applicable covenants of our Credit Agreement. We do not believe that these covenants represent a significant restriction in our ability to operate our business or to pay our dividends.

Table MD&A 11: Reconciliation of Net Income to Consolidated EBITDA as defined by our Credit Agreement

(in thousands)

For the Three Months Ended March 31, 2024 For the Trailing Twelve Months Ended March 31, 2024
Net income $80,510 $234,667
Adjustments:
Interest expense 20,366 83,406
Other expense/(income), net (822) 1,112
Provision for income taxes 27,440 73,330
Amortization of intangibles 21,641 92,413
Stock compensation expense 8,697 33,703
Acquisition-related expenses 226 1,257
Loss on sale of businesses — 1,018
Depreciation and amortization of property, equipment, and capitalized software 8,205 45,020
Pro forma and other adjustments permitted by our Credit Agreement 19,594 89,692
Consolidated EBITDA (as defined by our Credit Agreement) $185,857 $655,618

(in thousands, except ratio data)

Table MD&A 12: Consolidated Net Total Leverage Ratio For the Trailing Twelve Months Ended March 31, 2024
Funded Debt (as defined by our Credit Agreement) $1,216,187
Cash and cash equivalents up to $75 million 75,000
Consolidated Net Total Leverage (as defined by our Credit Agreement) $1,141,187
Consolidated Net Total Leverage Ratio (as defined by our Credit Agreement) 1.74

(in thousands, except ratio data)

Table MD&A 13: Consolidated Net Interest Coverage Ratio For the Trailing Twelve Months Ended March 31, 2024
Consolidated EBITDA (as defined by our Credit Agreement) $655,618
Interest expense 83,406
Components of other income/expense, net allowed in ratio calculation 4,252
Consolidated Net Interest Expense (as defined by our Credit Agreement) $87,658
Consolidated Net Interest Coverage Ratio (as defined by our Credit Agreement) 7.48

Cash in Foreign Locations

We have no requirement to remit funds from our foreign locations to the United States. We will continue to explore opportunities to remit additional funds, taking into consideration the working capital requirements and relevant tax rules in each jurisdiction. When we are unable to remit funds back without incurring a penalty, we will consider these funds indefinitely reinvested until such time as these restrictions are changed. As a result, we do not record U.S. deferred income taxes on any funds held in foreign jurisdictions. We have not attempted to calculate our potential liability from any transfer of these funds, as any such transaction might include tax planning strategies that we have not fully explored. Accordingly, it is not possible to estimate the potential tax obligations if we were to remit all of our funds from foreign locations to the United States.

Free Cash Flow (Non-GAAP)

Table MD&A 14: Free Cash Flow (Non-GAAP)

(in thousands)

For the Six Months Ended March 31, 2024 March 31, 2023
Net cash provided by operating activities $152,096 $175,037
Purchases of property and equipment and capitalized software (47,547) (33,751)
Free cash flow (Non-GAAP) $104,549 $141,286

Critical Accounting Policies and Estimates

The preparation of financial statements in conformity with accounting principles generally accepted in the U.S. requires us to make estimates, judgments, and assumptions that affect the amounts reported. Actual results could differ from those estimates. The 2023 Form 10-K, as filed with the SEC on November 16, 2023, includes a summary of critical accounting policies we believe are the most important to aid in understanding our financial results. There have been no changes to those critical accounting policies that have had a material impact on our reported amounts of assets, liabilities, revenues, or expenses during the three or six months ended March 31, 2024.

Non-GAAP and Other Measures

We utilize non-GAAP measures where we believe it will assist users of our financial statements in understanding our business. The presentation of these measures is meant to complement, but not replace, other financial measures in this document. The presentation of non-GAAP numbers is not meant to be considered in isolation, nor as an alternative to revenue growth, cash flows from operating activities, net income, or earnings per share as measures of performance. These non-GAAP measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

For the three months ended March 31, 2024, 12% of our revenue was generated outside the U.S. We believe that users of our financial statements wish to understand the performance of our foreign operations using a methodology that excludes the effect of year-over-year exchange rate fluctuations. To calculate year-over-year currency movement, we determine the current fiscal period's results for all foreign businesses using the exchange rates in the prior fiscal period.

In recent years, we have made a number of acquisitions and divestitures. We believe users of our financial statements wish to evaluate the performance of our operations, excluding changes that have arisen due to businesses acquired or disposed of. We identify acquired revenue and cost of revenue by showing these results for periods for which no comparative results exist within our financial statements. We identify revenue and cost of revenue that has been disposed of in a similar manner. This information is supplemented by our calculations of organic growth. To calculate organic growth, we compare current fiscal period results excluding transactions from acquisitions or disposals, to our prior fiscal period results.

Our recent acquisitions have resulted in significant intangible assets, which are amortized over their estimated useful lives. We believe users of our financial statements wish to understand the performance of the business by using a methodology that excludes the amortization of our intangible assets. For the six months ended March 31, 2023 and 2024, we also incurred losses on sales of businesses. We believe that providing supplemental measures that exclude the impact of the items detailed below is useful to investors in evaluating our core operations and results in relation to past periods. Accordingly, we have calculated our operating income, net income, and diluted earnings per share, excluding the effect of the amortization of intangible assets and divestiture-related charges. We have included a table showing our reconciliation of these income measures to their corresponding GAAP measures.

Table MD&A 15: Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets and Divestiture-Related Charges

(dollars in thousands, except per share data)

For the Three Months Ended March 31, 2024 March 31, 2023 For the Six Months Ended March 31, 2024 March 31, 2023
Operating income $127,494 $62,505 $235,004 $137,282
Add back: Amortization of intangible assets 21,641 23,650 44,990 47,168
Add back: Divestiture-related charges — 883 1,018 883
Adjusted operating income excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) $149,135 $87,038 $281,012 $185,333
Adjusted operating income margin excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) 11.1% 7.2% 10.5% 7.5%
Net income $80,510 $31,788 $144,658 $71,783
Add back: Amortization of intangible assets, net of tax 15,949 17,446 33,158 34,806
Add back: Divestiture-related charges — 883 1,018 883
Adjusted net income excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) $96,459 $50,117 $178,834 $107,472
Diluted earnings per share $1.31 $0.52 $2.35 $1.17
Add back: Effect of amortization of intangible assets on diluted earnings per share 0.26 0.28 0.53 0.57
Add back: Effect of divestiture-related charges on diluted earnings per share — 0.01 0.02 0.01
Adjusted diluted earnings per share excluding amortization of intangible assets and divestiture-related charges (Non-GAAP) $1.57 $0.81 $2.90 $1.75

In order to sustain our cash flows from operations, we regularly refresh our fixed assets and technology. We believe that users of our financial statements wish to understand the cash flows that directly correspond with our operations and the investments we must make in those operations using a methodology that combines operating cash flows and capital expenditures. We provide free cash flow to complement our statement of cash flows. Free cash flow shows the effects of our operations and replacement capital expenditures and excludes the cash flow effects of acquisitions, purchases of our common stock, dividend payments, and other financing transactions. We have provided a reconciliation of cash flows from operations to free cash flow in "Liquidity and Capital Resources."

To sustain our operations, our principal source of financing comes from receiving payments from our customers. We believe that users of our financial statements wish to evaluate our efficiency in converting revenue into cash receipts. Accordingly, we provide DSO, which we calculate by dividing billed and unbilled receivable balances at the end of each quarter by revenue per day for the quarter. Revenue per day for a quarter is determined by dividing total revenue by 91 days.

Market risk

As filed, 512 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

In the normal course of business, we are exposed to financial risks such as changes in interest rates, foreign currency exchange rates, and counterparty risk. We use derivative instruments to manage selected interest rate exposures. The Company's market rate risk disclosures set forth in Part II, Item 7A, "Quantitative and Qualitative Disclosures About Market Risk" on the 2023 Form 10-K, as filed with the SEC on November 16, 2023, have not changed materially during the six month period ended March 31, 2024.

Controls and procedures

As filed, 1,542 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this Quarterly Report on Form 10-Q. Based on this evaluation, our principal executive officer and principal financial officer concluded that these disclosure controls and procedures were effective and designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized and reported within the time periods specified by the Securities and Exchange Commission’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control Over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during our last fiscal quarter that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

Risk factors

As filed, 182 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.

There were no material changes during the six months ended March 31, 2024, to the risk factors previously disclosed in the 2023 Form 10-K, as filed with the SEC on November 16, 2023.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2024-03-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2024-01-01 to 2024-03-31$1.35bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Revenue6 months2023-10-01 to 2024-03-31$2.68bnus-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue3 months2024-01-01 to 2024-03-31$1.03bnus-gaap:CostOfRevenue
Cost of revenue6 months2023-10-01 to 2024-03-31$2.06bnus-gaap:CostOfRevenue
Gross profit3 months2024-01-01 to 2024-03-31$317.6mus-gaap:GrossProfit
Gross profit6 months2023-10-01 to 2024-03-31$617.6mus-gaap:GrossProfit
Selling, general and administrative3 months2024-01-01 to 2024-03-31$168.5mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative6 months2023-10-01 to 2024-03-31$337.6mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2024-01-01 to 2024-03-31$127.5mus-gaap:OperatingIncomeLoss
Operating income6 months2023-10-01 to 2024-03-31$235.0mus-gaap:OperatingIncomeLoss
Income tax3 months2024-01-01 to 2024-03-31$27.4mus-gaap:IncomeTaxExpenseBenefit
Income tax6 months2023-10-01 to 2024-03-31$48.8mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2024-01-01 to 2024-03-31$80.5mus-gaap:NetIncomeLoss
Net income6 months2023-10-01 to 2024-03-31$144.7mus-gaap:NetIncomeLoss
Diluted EPS3 months2024-01-01 to 2024-03-31$1.31us-gaap:EarningsPerShareDiluted
Diluted EPS6 months2023-10-01 to 2024-03-31$2.35us-gaap:EarningsPerShareDiluted
Basic EPS3 months2024-01-01 to 2024-03-31$1.31us-gaap:EarningsPerShareBasic
Basic EPS6 months2023-10-01 to 2024-03-31$2.36us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2024-01-01 to 2024-03-3161,622,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)6 months2023-10-01 to 2024-03-3161,573,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Operating cash flow6 months2023-10-01 to 2024-03-31$152.1mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure6 months2023-10-01 to 2024-03-31$47.5mus-gaap:PaymentsToAcquireProductiveAssets
Cash and equivalentsAt period end2024-03-31$77.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2024-03-31$1.12bnus-gaap:AssetsCurrent
Total assetsAt period end2024-03-31$4.04bnus-gaap:Assets
Current liabilitiesAt period end2024-03-31$728.7mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2024-03-31$2.25bnus-gaap:Liabilities
Long-term debtAt period end2024-03-31$1.12bnus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2024-03-31$88.5mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2024-03-31$1.79bnus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001032220-24-000050. Last ingested by Listed: Oct 24, 2026, 15:04 ET. Listed shows no prices and gives no investment advice.